Intercept Telemed Revenue and Competitors
Estimated Revenue & Valuation
- Intercept Telemed's estimated annual revenue is currently $652.5k per year.
- Intercept Telemed's estimated revenue per employee is $72,500
Employee Data
- Intercept Telemed has 9 Employees.
- Intercept Telemed grew their employee count by 50% last year.
Intercept Telemed's People
Name | Title | Email/Phone |
---|
Intercept Telemed Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8.7M | 67 | 14% | N/A | N/A |
#2 | $27.3M | 175 | -3% | $10M | N/A |
#3 | $265.1M | 1306 | -16% | N/A | N/A |
#4 | $8.9M | 68 | -8% | N/A | N/A |
#5 | $28.4M | 178 | -12% | N/A | N/A |
#6 | $5M | 45 | 13% | $16.8M | N/A |
#7 | $36.2M | 227 | -8% | N/A | N/A |
#8 | $19.7M | 136 | 5% | N/A | N/A |
#9 | $12.9M | 89 | 5% | $7M | N/A |
#10 | $231M | 1138 | 9% | N/A | N/A |
What Is Intercept Telemed?
At Intercept TeleMed, we have designed a Tele-ICU services company that is led by physicians who have an in-depth understanding of the challenges within an ICU and skilled at creating improved outcomes. Dr. Diego Reino, founder of Intercept, has had both the privilege and responsibility of caring for the sickest patients in the ICU throughout his career. His greatest frustrations have always arisen from patients suffering adverse events because of sub-optimal bedside staffing or delayed access to critical patient data. Having more timely access to this information, as well as skilled intensivists, alters patient outcomes, avoids unnecessary complications and, in many cases, decreases mortality.
keywords:N/AN/A
Total Funding
9
Number of Employees
$652.5k
Revenue (est)
50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.7M | 9 | -10% | N/A |
#2 | $0.7M | 9 | -18% | N/A |
#3 | $1.5M | 10 | N/A | N/A |
#4 | $1.8M | 11 | -73% | N/A |
#5 | $1M | 11 | 57% | N/A |